SPARC:可编程药物组合的多重负载ADC架构
Wenlong Sun1, Weining Weng2, Jing Shi3
1HuaO Therapeutics, Shanghai 200441, China.
Bioconjugate chemistry
|September 17, 2025
概括
协同有效载荷-抗体比度结合物 (SPARCs) 通过在最佳比率下提供多种药物,使得精确的组合癌症治疗成为可能. 与传统方法相比,这种方法提高了疗效,降低了毒性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物结合化学 生物结合化学
背景情况:
- 药物组合在瘤学中至关重要,但往往受到毒性和不良向的限制.
- 抗体 - 药物联体 (ADC) 提供单个有效载荷,但在多重有效载荷的交付方面遇到困难.
- 现有的多重载荷ADC缺乏有效载荷协同作用的知识,并面临复杂的工程挑战.
研究的目的:
- 设计一个新的多重负载ADC平台,协同有效负载-抗体比度结合物 (SPARC),用于精确的组合疗法.
- 为优化药物组合阐明依赖有效载荷比的药理学和毒理学.
- 开发一个可编程的平台,用于组装具有可调节的有效载荷比率和高药物抗体比率 (DAR) 的SPARC.
主要方法:
- 合成多T1000有效载荷 (MTP) 部分,使用正交的亚酸基因点击化学.
- 结合MTP与THIOMABs的原生抗体或工程化囊蛋白,以创建具有2-6个有效载荷的SPARC.
- 评估了SPARC的稳定性,同质性,抗体结合,体内药理学和毒理学.
主要成果:
- 实现了可编程的SPARC组件,具有2-6个有效载荷,DAR高达30个,可调节的有效载荷比率 (1-10).
- SPARCs表现出稳定性,同质性,并保持了抗体结合.
- 在体内研究表明,由于同步的有效载荷传递和协同相互作用,减少了目标外毒性和提高了有效性.
- 结合Topoisomerase I (TOP1) 和DNA损伤反应 (DDR) 抑制剂的SPARCs优于单个有效载荷ADC和免费药物组合.
结论:
- 在瘤学中,SPARC代表了精密组合治疗的变革性方法.
- 这个平台可以实现合理的药物代码交付,可能会将废弃的药物重新用作有效载荷.
- SPARCs提供了更好的安全性和有效性,解决了癌症治疗和其他疾病的未满足需求.
相关概念视频
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
222
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
222
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Dosage Regimens: Designs and Approaches
266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266
Drug Delivery: Overview
730
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
730


